In an adult with symptomatic knee osteoarthritis and no contraindications, how often can intra‑articular Supartz (sodium hyaluronate) be administered?

Supartz Injection Frequency for Knee Osteoarthritis

Supartz (sodium hyaluronate) is administered as a course of 5 weekly injections, with repeat courses permitted every 6 months based on symptom recurrence. 1

Standard Dosing Protocol

• The initial treatment course consists of one 2.5 mL intra-articular injection administered once weekly for 5 consecutive weeks. 2
• Pain relief typically peaks approximately one week after completing the 5-injection series and can persist for 3-6 months without additional treatment. 1, 2
• The effective duration of a single 5-week course provides clinically meaningful pain reduction and functional improvement for up to 6 months. 1

Repeat Course Administration

• Repeated courses of Supartz can be administered when symptoms recur, typically at 6-12 month intervals based on individual patient response. 3
• Repeated courses maintain the same safety profile as initial treatment, with an extremely low risk of infection or serious adverse events. 1
• Long-term data over 54 months demonstrates that repeated cycles every 6-12 months can delay the need for total knee replacement in patients who respond to initial treatment. 3

Clinical Context and Patient Selection

• Supartz is most appropriate for patients with mild-to-moderate knee osteoarthritis (Ahlback grades I-III) who have failed conservative management with acetaminophen and NSAIDs. 4, 3
• The decision to repeat treatment should be based on the magnitude and duration of benefit from the previous course; patients who achieved good initial response are candidates for repeat administration. 3

Important Safety Considerations

• Avoid hyaluronic acid injections within 3 months prior to planned total knee replacement surgery due to theoretical increased infection risk. 5, 6
• Maintain strict aseptic technique during all intra-articular injections to minimize infection risk. 5
• The most common adverse events are transient injection site pain; no systemic or serious adverse events have been reported in clinical trials. 4

Comparison to Corticosteroid Injections

• Unlike corticosteroid injections (which should be limited to every 3 months with maximum 3-4 injections per year), hyaluronic acid courses can be repeated more liberally at 6-12 month intervals without cumulative joint damage concerns. 5, 7
• Hyaluronic acid provides a slower onset of action than corticosteroids but offers more prolonged benefit, making it suitable for maintenance therapy rather than acute flares. 8

Alternative Dosing Regimens

• Some sodium hyaluronate formulations use a 3-4 weekly injection protocol rather than 5 weeks, though Supartz specifically follows the 5-injection regimen. 4, 3
• The 3-weekly protocol has demonstrated similar efficacy with significant WOMAC score improvements maintained over 6 months. 4